Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
| ▸ | CCR8 | P51685 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS1 | P29475 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL27839384 | 0.98 | UHRF1 (0.45) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL2643186 | 0.81 | UHRF1 (0.48) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL1464557 | 0.79 | UHRF1 (0.46) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL1824530 | 0.79 | UHRF1 (0.46) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL3675739 | 0.79 | KDM4E (0.48) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL30845679 | 0.79 | KDM4E (0.48) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL2642943 | 0.78 | UHRF1 (0.45) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL3439204 | 0.78 | UHRF1 (0.45) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL31527805 | 0.78 | KDM4E (0.47) | UHRF1CCR1CCR5CCR8KDM4E | |
| SCHEMBL8847160 | 0.77 | ALDH1A1 (0.41) | CCR1CCR5CCR8KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501236-B1 | N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer | PLEXXIKON INC (US) | 2017-03-29 | — | — | EP | claimed |
| CN-106458903-B | Method for producing heteroaromatic sulfonamide compound | 宇部兴产株式会社 | 2021-02-05 | — | — | CN | disclosed |
| CN-108950645-B | Aluminum and aluminum alloy anodic oxidation nickel-free sealing agent | 上海铝通化学科技有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-20200035419-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTOSENSITIVE-LAYER-FORMING COMPOSITION | FUJIFILM CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| EP-3509117-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR BATTERY, METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, AND SURFACE TREATMENT AGENT FOR PEROVSKITE-TYPE CRYSTAL FILM | FUJIFILM Corporation (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190189362-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT, AND SURFACE TREATING AGENT FOR PEROVSKITE-TYPE CRYSTAL FILM | FUJIFILM CORPORATION (JP) | 2019-06-20 | — | — | US | disclosed |
| EP-3156395-B1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE INDUSTRIES (JP) | 2019-01-09 | — | — | EP | disclosed |
| CN-108950645-A | A kind of aluminium and aluminium alloy anode oxide are without nickel sealer | 上海铝通化学科技有限公司 | 2018-12-07 | — | — | CN | disclosed |
| US-20170121288-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3156395-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | UBE Industries, Ltd. (JP) | 2017-04-19 | — | — | EP | disclosed |
| US-9617267-B2 | Compounds and methods for kinase modulation, and indications therefor | PLEXXIKON INC. (US) | 2017-04-11 | — | — | US | disclosed |
| EP-2501236-B1 | N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer | PLEXXIKON INC (US) | 2017-03-29 | — | — | EP | disclosed |
| CN-106458903-A | Method for producing heteroaromatic sulfonamide compound | 宇部兴产株式会社 | 2017-02-22 | — | — | CN | disclosed |
| US-20140288070-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC. | 2014-09-25 | — | — | US | disclosed |
| US-8673928-B2 | Compounds and methods for kinase modulation, and indications therefor | PLEXXIKON INC. (US) | 2014-03-18 | — | — | US | disclosed |
| EP-2501236-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | Plexxikon, Inc. (US) | 2012-09-26 | — | — | EP | disclosed |
| EP-0526849-B1 | Substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof | DAIKIN IND LTD (JP) | 1999-12-01 | — | — | EP | disclosed |
| CN-1117294-A | Substituted fused pyrazolo compounds and their use as herbicides | ZENECA LTD (GB) | 1996-02-21 | — | — | CN | disclosed |
| US-5374732-A | Chemical intermediates as fluorination agents | DAIKIN INDUSTRIES, LTD. (JP) | 1994-12-20 | — | — | US | disclosed |
| EP-0526849-A1 | Novel substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof | DAIKIN INDUSTRIES, LTD. (JP) | 1993-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170121288-A1 | METHOD FOR PRODUCING HETEROAROMATIC SULFONAMIDE COMPOUND | PFAS, SULT2A1, ARSA | UHRF1 2205/4885CCR1 4496/4885CCR5 4593/4885 |
| US-20140288070-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | BRAF, KRAS, RAF1 | UHRF1 2767/4885CCR1 2601/4885CCR5 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.